Page last updated: 2024-08-20

dextrothyroxine and Cytomegalovirus Infections

dextrothyroxine has been researched along with Cytomegalovirus Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ashida, C; Funauchi, M; Kinoshita, K; Nozaki, Y1
Acharya, KB; Bariola, JR; Lamps, L; Quick, CM; Wells, MA; Young, DR1

Other Studies

2 other study(ies) available for dextrothyroxine and Cytomegalovirus Infections

ArticleYear
Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
    BMC infectious diseases, 2020, Jul-02, Volume: 20, Issue:1

    Topics: Aged; Animals; Anthelmintics; Antiviral Agents; Coinfection; Cytomegalovirus; Cytomegalovirus Infections; Fatal Outcome; Female; Ganciclovir; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Ivermectin; Lupus Erythematosus, Systemic; Strongyloides stercoralis; Strongyloidiasis; Syndrome

2020
A vicious cycle.
    The American journal of medicine, 2012, Volume: 125, Issue:4

    Topics: Antiparasitic Agents; Colitis; Crohn Disease; Cytomegalovirus Infections; Female; Glucocorticoids; Humans; Ivermectin; Middle Aged; Prednisone; Strongyloidiasis

2012